BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28381800)

  • 1. Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets.
    Sotoyama M; Uchida S; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Biol Pharm Bull; 2017; 40(4):451-457. PubMed ID: 28381800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability.
    Matsui R; Uchida S; Namiki N
    Biol Pharm Bull; 2015; 38(1):17-22. PubMed ID: 25744453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
    Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
    J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical Palatability.
    Takano H; Uchida S; Kashiwagura Y; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Chem Pharm Bull (Tokyo); 2019; 67(2):112-119. PubMed ID: 30713270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of bitter taste-masked orally disintegrating tablets of high memantine hydrochloride loaded granules coated with polymer via layering technique.
    Kadota K; Terada H; Fujimoto A; Nogami S; Uchiyama H; Tozuka Y
    Int J Pharm; 2021 Jul; 604():120725. PubMed ID: 34029663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
    Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the palatabilities in 10 different famotidine orally disintegrating tablets by combination of disintegration device and taste sensor.
    Yoshida M; Hazekawa M; Haraguchi T; Uchida T
    Drug Dev Ind Pharm; 2015; 41(8):1387-92. PubMed ID: 25196898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets.
    Kimura S; Uchida S; Kanada K; Namiki N
    Int J Pharm; 2015 Apr; 484(1-2):156-62. PubMed ID: 25681720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
    Shah PP; Mashru RC
    AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating method.
    Sugiura T; Uchida S; Namiki N
    Chem Pharm Bull (Tokyo); 2012; 60(3):315-9. PubMed ID: 22382410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets.
    Nakano Y; Maeda A; Uchida S; Namiki N
    Int J Pharm; 2013 Mar; 446(1-2):160-5. PubMed ID: 23419665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
    Labib GS
    Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ease of Taking and Palatability of Fixed-Dose Orally Disintegrating Mitiglinide/Voglibose Tablets.
    Sotoyama M; Uchida S; Kamiya C; Tanaka S; Kashiwagura Y; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Chem Pharm Bull (Tokyo); 2019; 67(6):540-545. PubMed ID: 31155559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus.
    Harada T; Uchida T; Yoshida M; Kobayashi Y; Narazaki R; Ohwaki T
    Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1009-14. PubMed ID: 20686251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
    Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prediction of the palatability of orally disintegrating tablets by an electronic gustatory system.
    Nakamura H; Uchida S; Sugiura T; Namiki N
    Int J Pharm; 2015 Sep; 493(1-2):305-12. PubMed ID: 26216412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
    Ge Z; Yang M; Wang Y; Shan L; Gao C
    Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
    Drašković M; Medarević D; Aleksić I; Parojčić J
    Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
    Stange U; Führling C; Gieseler H
    J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.